• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发垂体卒中-海绵窦侵袭是再出血的主要危险因素。

Multiple Pituitary Apoplexy-Cavernous Sinus Invasion as Major Risk Factor for Recurrent Hemorrhage.

机构信息

Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.

Institute of Neurology, Medical University of Vienna, Vienna, Austria.

出版信息

World Neurosurg. 2019 Jun;126:e723-e730. doi: 10.1016/j.wneu.2019.02.138. Epub 2019 Mar 7.

DOI:10.1016/j.wneu.2019.02.138
PMID:30851467
Abstract

OBJECTIVE

Pituitary apoplexy is a rare but potentially life-threatening disorder that occurs in up to 10% of adenomas. Whereas risk factors for the initial hemorrhagic event are well described, there is minor knowledge on clinical symptomatic recurrent pituitary apoplexies.

METHODS

At the Medical University of Vienna, 76 patients were surgically treated for clinical symptomatic pituitary apoplexy between 1990 and 2017. Four patients (5.3%) suffered multiple pituitary apoplexies after initial surgery. In this retrospective study, neuroradiologic images, clinical data, and intraoperative findings were reviewed for potential risk factors of multiple apoplexies in pituitary adenomas.

RESULTS

Patients with multiple apoplexies had significantly higher Knosp grading on preoperative imaging (median grade 4), and more frequently observed cavernous sinus invasion intraoperatively (P = 0.01). Consequently, all cases with multiple pituitary apoplexies remained with residual adenoma postoperatively. In cases of residual tumor within the cavernous sinus, recurrent apoplexy occurred in 23.5% of patients. A tumor recurrence/residual was resected significantly earlier in patients with single apoplexy (median 2.2 years) than in patients with multiple apoplexies (median 5.4 years; P = 0.05). Multiple pituitary apoplexies caused significantly greater rates of ophthalmoplegia (75% vs. 14.1%; P = 0.01) and long-term hormone-replacement therapy was necessary in all cases.

CONCLUSIONS

Cavernous sinus invasion and subtotal resection are high risk factors for multiple apoplexies in pituitary adenomas. Early treatment is recommended for residual tumor in the cavernous sinus to minimize the risk of recurrent apoplexy with subsequent worse clinical outcome.

摘要

目的

垂体卒中是一种罕见但潜在危及生命的疾病,在 10%的腺瘤中发生。虽然最初出血事件的风险因素已得到很好的描述,但对于临床症状性复发性垂体卒中的了解甚少。

方法

在维也纳医科大学,1990 年至 2017 年间,有 76 名患者因临床症状性垂体卒中接受了手术治疗。4 名患者(5.3%)在初次手术后多次发生垂体卒中。在这项回顾性研究中,对神经放射图像、临床数据和术中发现进行了回顾,以寻找垂体腺瘤多次发生卒中的潜在危险因素。

结果

多次发生卒中的患者术前影像学 Knosp 分级显著更高(中位数 4 级),术中更频繁地观察到海绵窦侵袭(P=0.01)。因此,所有多次发生垂体卒中的病例术后均残留腺瘤。在海绵窦内有肿瘤残留的情况下,75%的患者再次发生卒中。在单次卒中的患者中,肿瘤复发/残留的切除时间明显早于多次卒中的患者(中位数 2.2 年与 5.4 年;P=0.05)。多次垂体卒中导致眼肌麻痹的发生率显著更高(75%与 14.1%;P=0.01),所有病例均需要长期激素替代治疗。

结论

海绵窦侵袭和次全切除是垂体腺瘤多次发生卒中的高危因素。对于海绵窦内的肿瘤残留,建议早期治疗,以最大程度地降低再次发生卒中的风险,从而避免后续更差的临床结局。

相似文献

1
Multiple Pituitary Apoplexy-Cavernous Sinus Invasion as Major Risk Factor for Recurrent Hemorrhage.多发垂体卒中-海绵窦侵袭是再出血的主要危险因素。
World Neurosurg. 2019 Jun;126:e723-e730. doi: 10.1016/j.wneu.2019.02.138. Epub 2019 Mar 7.
2
Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes.肢端肥大症患者侵袭海绵窦肿瘤的积极经蝶窦切除术:预测因素、策略及结果
J Neurosurg. 2014 Sep;121(3):505-10. doi: 10.3171/2014.3.JNS132214. Epub 2014 Jul 11.
3
A possible mechanism of isolated oculomotor nerve palsy by apoplexy of pituitary adenoma without cavernous sinus invasion: a report of two cases.垂体瘤卒中致孤立性动眼神经麻痹的可能机制,未侵犯海绵窦:两例报告。
Acta Neurochir (Wien). 2011 Dec;153(12):2453-6; discussion 2456. doi: 10.1007/s00701-011-1165-4. Epub 2011 Sep 27.
4
Time Course of Symptomatic Recovery After Endoscopic Transsphenoidal Surgery for Pituitary Adenoma Apoplexy in the Modern Era.现代垂体腺瘤卒中经蝶窦内镜手术后症状恢复的时间进程
World Neurosurg. 2016 Dec;96:434-439. doi: 10.1016/j.wneu.2016.09.052. Epub 2016 Sep 20.
5
Surgical Outcomes of Cavernous Sinus Syndrome in Pituitary Adenomas.垂体腺瘤所致海绵窦综合征的手术疗效
World Neurosurg. 2017 Nov;107:526-533. doi: 10.1016/j.wneu.2017.08.049. Epub 2017 Aug 18.
6
Ischemic pituitary adenoma apoplexy-Clinical appearance and prognosis after surgical intervention.缺血性垂体腺瘤卒中——手术干预后的临床表现及预后
Clin Neurol Neurosurg. 2016 Sep;148:142-6. doi: 10.1016/j.clineuro.2016.07.013. Epub 2016 Jul 7.
7
Pituitary apoplexy in the magnetic resonance imaging era: clinical significance of sphenoid sinus mucosal thickening.磁共振成像时代的垂体卒中:蝶窦黏膜增厚的临床意义
J Neurosurg. 2006 Jun;104(6):892-8. doi: 10.3171/jns.2006.104.6.892.
8
Pituitary apoplexy: An emergent and potential life-threatening complication of pituitary adenomas.垂体卒中:一种垂体腺瘤的紧急且潜在危及生命的并发症。
Ulus Travma Acil Cerrahi Derg. 2022 Apr;28(4):483-489. doi: 10.14744/tjtes.2021.93539.
9
Pituitary apoplexy: large surgical series with grading system.垂体卒中:大型手术系列及分级系统。
World Neurosurg. 2014 Nov;82(5):781-90. doi: 10.1016/j.wneu.2014.06.005. Epub 2014 Jun 8.
10
Late recurrent bleeding after surgical treatment for pituitary apoplexy.垂体卒中手术治疗后的晚期复发性出血。
J Clin Neurosci. 2004 Jun;11(5):555-9. doi: 10.1016/j.jocn.2003.07.006.

引用本文的文献

1
Pituitary apoplexy: a systematic review of non-gestational risk factors.垂体卒中:非妊娠相关风险因素的系统综述。
Pituitary. 2024 Aug;27(4):320-334. doi: 10.1007/s11102-024-01412-0. Epub 2024 Jun 27.
2
Exploring risk factors of severe pituitary apoplexy: Insights from a multicenter study of 71 cases.探索严重垂体卒中的危险因素:来自一项71例多中心研究的见解
Endocrine. 2024 Oct;86(1):333-341. doi: 10.1007/s12020-024-03918-w. Epub 2024 Jun 8.
3
Clinical and therapeutic implications of cavernous sinus invasion in pituitary adenomas.
海绵窦侵袭性垂体腺瘤的临床与治疗意义。
Endocrine. 2024 Sep;85(3):1058-1065. doi: 10.1007/s12020-024-03877-2. Epub 2024 May 18.
4
Diagnosis and management of pituitary apoplexy: a Tunisian data.垂体卒中的诊断与管理:突尼斯的数据。
Chin Neurosurg J. 2023 Jul 1;9(1):17. doi: 10.1186/s41016-023-00331-6.
5
A Case of Pituitary Apoplexy and Cavernous Sinus Syndrome during Hemodialysis.1例血液透析期间发生的垂体卒中合并海绵窦综合征
Case Rep Endocrinol. 2023 Apr 25;2023:3183088. doi: 10.1155/2023/3183088. eCollection 2023.
6
Pituitary Apoplexy in Patients with Pituitary Neuroendocrine Tumors (PitNET).垂体神经内分泌肿瘤(PitNET)患者的垂体卒中
Biomedicines. 2023 Feb 23;11(3):680. doi: 10.3390/biomedicines11030680.
7
Predictive Clinical and Surgical Factors Associated with Recurrent Apoplexy in Pituitary Adenomas.垂体腺瘤复发性卒中相关的预测性临床和手术因素
J Neurol Surg B Skull Base. 2021 Sep 10;83(Suppl 2):e591-e597. doi: 10.1055/s-0041-1735636. eCollection 2022 Jun.